Tag Archives: Xoma Corp

Wedbush Keeps Their Buy Rating on Xoma Corp (XOMA)

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Xoma Corp (XOMA – Research Report), with a price target of $25. The company’s shares closed yesterday at $15.99. According to TipRanks.com, Moussatos ‘ ranking currently

Xoma Corp (XOMA) Receives a Buy from Wedbush

Wedbush analyst Liana Moussatos reiterated a Buy rating on Xoma Corp (XOMA – Research Report) today and set a price target of $25. The company’s shares opened today at $18.26. According to TipRanks.com, Moussatos is currently ranked with no stars

A Director at Xoma Corp (NASDAQ: XOMA) is Selling Shares

Today, a Director at Xoma Corp (XOMA – Research Report), Denman Van-Ness, sold shares of XOMA for $1,911. Following Denman Van-Ness’ last XOMA Sell transaction on December 21, 2018, the stock climbed by 3.3%. See today’s analyst top recommended stocks

Analysts Offer Insights on Healthcare Companies: Xoma Corp (NASDAQ: XOMA), Acelrx (NASDAQ: ACRX) and CytoDyn Inc (Other OTC: CYDY)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Xoma Corp (XOMA – Research Report), Acelrx (ACRX – Research Report) and CytoDyn Inc (CYDY – Research Report) with bullish sentiments. Xoma

Wedbush Reiterates a Buy Rating on Xoma Corp (XOMA)

Wedbush analyst Liana Moussatos reiterated a Buy rating on Xoma Corp (XOMA – Research Report) yesterday and set a price target of $26. The company’s shares opened today at $14.91. According to TipRanks.com, Moussatos has currently no stars on a

A Director at Xoma Corp (NASDAQ: XOMA) is Buying Shares

Today, a Director at Xoma Corp (XOMA – Research Report), Denman Van-Ness, bought shares of XOMA for $10.4K. Following this transaction Denman Van-Ness’ holding in the company was increased by 8.63% to a total of $114.3K. In addition to Denman